• Noah Derm Society 67th Annual Meeting - San Antonio, Texas

    67th Annual Meeting

    April 22-26 | JW Marriot Hill Country | San Antonio, TX

  • Cocktails with Noah at AAD

    Cocktails With Noah at AAD

    March 27, 2026 | Denver, CO

  • Noah Derm Society Annual Meeting Sponsorship Opportunities

    Thank you Noah Sponsors!

    Thank you to the loyal supporters of Noah - your generosity makes the Noah Annual Meeting possible!

  • Noah Derm Society 68th Annual Meeting - Barcelona, Spain

    68th Annual Meeting

    June 2027 | Barcelona, Spain

Advancing Dermatology Through Connection, Curiosity, and Community

The Noah Worcester Dermatological Society (Noah Derm) is a vibrant, collegial community of board-certified dermatologists committed to advancing the specialty through connection, education, and shared purpose.

Founded in 1961, Noah Derm brings together dermatology leaders and emerging voices in an intimate, retreat-style annual meeting that fosters authentic dialogue, lifelong learning, and meaningful professional relationships. Named in honor of Noah Worcester, a pioneer of American dermatology, the Society continues his legacy of curiosity, integrity, and collaboration.

About Our Members

Number of members: 225

Average age: 50 years

Medical: 85%

Surgical: 48%

Cosmetic: 37%

Served on the Board: 29%

Served on a Committee: 51%

Have Presented: 70%

Involved in teaching programs: 64%

Directors of teaching programs: 11%

Published papers: 93%

New Member Spotlight:
Ata Moshiri, MD, MPH, FAAD

Dr. Moshiri is an Assistant Professor of Dermatology and Dermatopathology at the Ronald O. Perelman Department of Dermatology at New York University. He serves as the Director of Laboratory Operations of their high-volume dermatopathology service, and the Director of the Dermatopathology Fellowship Program. He is an active member of various national organizations, and serves on committees for the AAD, APD, and ASDP. Clinically, he has interests in melanoma and pigmented lesions, and specializes in the diagnosis and management of challenging melanocytic proliferations using molecular diagnostics.